Kings Point Capital Management’s DexCom DXCM Stock Holding History

Kings Point Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$21K	Hold	164	–	–	﹤0.01%	470
2021 Q4	$22K	Hold	164	–	–	﹤0.01%	520
2021 Q3	$22K	Sell	164 -16	-9%	-$2.02K	﹤0.01%	477
2021 Q2	$19K	Buy	180 +16	+10%	+$1.54K	﹤0.01%	469
2021 Q1	$15K	Hold	164	–	–	﹤0.01%	486
2020 Q4	$15K	Sell	164 -16	-9%	-$1.43K	﹤0.01%	449
2020 Q3	$19K	Buy	180 +16	+10%	+$1.67K	﹤0.01%	418
2020 Q2	$17K	Hold	164	–	–	﹤0.01%	382
2020 Q1	$11K	Buy	+164	New	+$10.2K	﹤0.01%	434

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kings Point Capital Management's DXCM Position: Q1 2022 in Review

Kings Point Capital Management held its DexCom (DXCM) position steady in Q1 2022 at 164 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

Kings Point Capital Management first reported a position in DXCM in Q1 2020 and has held it in 9 quarters since. The position peaked at $22K in Q4 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

Kings Point Capital Management held 164 shares of DexCom worth $21K as of Q1 2022.
Kings Point Capital Management left its DexCom share count unchanged in Q1 2022.
DexCom made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #470 holding.
Kings Point Capital Management first reported a position in DexCom in Q1 2020 and has held it in 9 quarters since.
Kings Point Capital Management's DexCom position peaked at $22K in Q4 2021.
861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.